Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Lumigan
Generic name / active ingredient
bimatoprost
Dosage-form class
Ophthalmic solution: 0.01% (0.1 mg/mL); this dossier displays the exact 5 mL fill in a 10 mL container, NDC 0023-3205-05
Route
Ophthalmic use
Record reviewed
2026-08-22

Copy from the pack in hand

Source-linked reading points

  • 0.01% and 0.1 mg/mL are two label formats for the concentration of this eye-drop solution; 5 mL is the fill volume of this exact panel and 10 mL is the stated container size. They help identify the product, not calculate how many drops anyone should use, how long it lasts or whether to make up use.
  • Eye drops cannot be self-combined, alternated or substituted merely because they mention glaucoma, eye pressure or prostaglandins. The label has product-specific checks involving other prostaglandin eye products, other drops and contact lenses; have an ophthalmologist or pharmacist review the actual bottles and complete eye/systemic medicine list.
  • The package image, NDC, fill volume and container size only help compare a source. They cannot authenticate a product, identify another bimatoprost package or confirm current storage and handling requirements. Any opening, storage, spacing from another eye drop, contact-lens or missed-use question must follow the current label and professional instructions for the exact product in hand.
  • The label includes warnings about iris, eyelid/eyelash changes, intraocular inflammation, macular oedema and bacterial keratitis. With vision change, marked eye pain, redness/swelling, injury or another acute eye concern, use local ophthalmic or urgent-care pathways promptly; this page does not decide self-continuation, pause or switching.

Reviewed presentation examples — compare every field

  • 0.01% (0.1 mg/mL); 5 mL fill in a 10 mL containerNDC 0023-3205-05

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-22
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image